Noile-Immune Biotech Alternatives & Competitors
12 companies similar to Noile-Immune Biotech — Pioneering the future of cancer immunotherapy with CAR-T cell advancements from...
Companies similar to Noile-Immune Biotech
Asgard Therapeutics
Swedish biotech company exploring reprogramming as the next leap forward in cancer immunot...
Lund, Sweden
SCG Cell Therapy
Leading the Next Wave of Biotech Breakthroughs
Singapore, Singapore
T Cell Nouveau
Clinical stage biopharmaceutical company with novel TCR like CAR-T cell therapy for solid...
Tokyo, Japan
TCR2
Pioneering the future of cancer treatment with advanced T cell engineering and unparallele...
Track all Noile-Immune Biotech competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
Cytovia Therapeutics
We empower Natural Killer cells to fight cancer through stem cell engineering and multispe...
Aventura, United States
Lyell Immunopharma
At Lyell, we are advancing next-generation CAR T-cell product candidates for patients with...
South San Francisco, Unit...
Alderaan Biotechnology
A preclinical stage biotech company developing novel therapies to treat cancer by targetin...
Paris, France
VAXIMM AG
Developing innovative oral T-cell immunotherapies to treat cancer patients
Basel, Switzerland
Tmunity Therapeutics
Pioneering the future of immunotherapy through innovative T cell engineering to tackle a d...
Alligator Bioscience
Pioneering advancements in immunotherapy with innovative drug candidates and proprietary t...
星尘生物科技(上海)有限公司
Pioneering affordable and swift cell therapy advancements for enhanced tumor treatment out...
About Noile-Immune Biotech
Noile-Immune Biotech is a pioneering cancer research organization specializing in the development of cancer immunotherapies using CAR-T cell therapy. The company, founded in 2015, has its origins in Yamaguchi University and aims to lead the future of cancer immunotherapy. Their recent ¥2.38B Series C investment on 22 M...
Cancer Immunotherapy, CAR-T Cell Therapy, Biotech, Cancer Research, Academic Innovation, Venture Company, Yamaguchi University, Medical Technology, Innovation, Biopharmaceuticals, Immunology, Cell Therapy, Research & Development, Oncology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Noile-Immune Biotech and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Noile-Immune Biotech on 25 Jul 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 16 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
